NVASC Trademark

Trademark Overview

On Monday, October 21, 2024, a trademark application was filed for NVASC with the United States Patent and Trademark Office. The USPTO has given the NVASC trademark a serial number of 98812225. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, October 21, 2024. This trademark is owned by NVasc, Inc.. The NVASC trademark is filed in the Computer & Software Services & Scientific Services and Pharmaceutical Products categories with the following description:

Pharmaceutical and biological preparations for medical use for the treatment of ophthalmological diseases and disorders; pharmaceutical and biological preparations for medical use for the treatment of neurological, cerebrovascular, cardiovascular and vascular diseases and disorders

Research and development relating to pharmaceuticals and biologics for the treatment of ophthalmological diseases and disorders; research and development relating to pharmaceuticals and biologics for the treatment of neurological, cerebrovascular, cardiovascular and vascular diseases and disorders; conducting evaluations in the field of new pharmaceuticals; pharmaceutical drug development services; pharmaceutical product evaluation
nvasc

General Information

Serial Number98812225
Word MarkNVASC
Filing DateMonday, October 21, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, October 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical and biological preparations for medical use for the treatment of ophthalmological diseases and disorders; pharmaceutical and biological preparations for medical use for the treatment of neurological, cerebrovascular, cardiovascular and vascular diseases and disorders
Goods and ServicesResearch and development relating to pharmaceuticals and biologics for the treatment of ophthalmological diseases and disorders; research and development relating to pharmaceuticals and biologics for the treatment of neurological, cerebrovascular, cardiovascular and vascular diseases and disorders; conducting evaluations in the field of new pharmaceuticals; pharmaceutical drug development services; pharmaceutical product evaluation

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 21, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 21, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNVasc, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAtherton, CA 94027

Trademark Events

Event DateEvent Description
Monday, October 21, 2024NEW APPLICATION ENTERED

Related Keywords

nvasc disorders pharmaceutical diseases treatment pharmaceuticals development research biologics relating cardiovascular